These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3093891)

  • 21. Narrow host range of AIDS-related retroviruses (YU-1, 2, 3, 4) isolated from Japanese hemophiliacs: inability to infect H9, Molt-4, and MT-4 cells.
    Yoshiyama H; Harada S; Kajii T; Yamamoto N
    Jpn J Cancer Res; 1986 Jun; 77(6):514-6. PubMed ID: 3015850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
    Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
    Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
    Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.
    Zarling JM; Eichberg JW; Moran PA; McClure J; Sridhar P; Hu SL
    J Immunol; 1987 Aug; 139(4):988-90. PubMed ID: 3497202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different H-2 subregions influence immunization against retrovirus and immunosuppression.
    Morrison RP; Earl PL; Nishio J; Lodmell DL; Moss B; Chesebro B
    Nature; 1987 Oct 22-28; 329(6141):729-32. PubMed ID: 2823142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
    Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC
    J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LAV type II: a second retrovirus associated with AIDS in West Africa].
    Clavel F; Brun-Vézinet F; Guétard D; Chamaret S; Laurent A; Rouzioux C; Rey M; Katlama C; Rey F; Champelinaud JL
    C R Acad Sci III; 1986; 302(13):485-8. PubMed ID: 3013382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [AIDS vaccines: an enigma in vaccine development].
    Dorner F; Barrett N
    Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.
    Hu SL; Zarling JM; Chinn J; Travis BM; Moran PA; Sias J; Kuller L; Morton WR; Heidecker G; Benveniste RE
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7213-7. PubMed ID: 2550935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of the development of an AIDS vaccine.
    Lasky LA
    Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques.
    Earl PL; Robert-Guroff M; Matthews TJ; Krohn K; London WT; Moss B
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):23-32. PubMed ID: 2541747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting.
    Sundling C; Martinez P; Soldemo M; Spångberg M; Bengtsson KL; Stertman L; Forsell MN; Karlsson Hedestam GB
    J Infect Dis; 2013 Feb; 207(3):426-31. PubMed ID: 23162135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.
    Murphey-Corb M; Martin LN; Rangan SR; Baskin GB; Gormus BJ; Wolf RH; Andes WA; West M; Montelaro RC
    Nature; 1986 May 22-28; 321(6068):435-7. PubMed ID: 3012358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV).
    Harada S; Kobayashi N; Koyanagi Y; Yamamoto N
    Virology; 1987 Jun; 158(2):447-51. PubMed ID: 2438845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
    Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
    Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B and T cell reactivities after immunization of macaques with HIV subcomponents.
    Wahren B; Chiodi F; Ljunggren K; Putney S; Kurth R; Gallo RC; Fenyö EM
    AIDS Res Hum Retroviruses; 1988 Jun; 4(3):199-210. PubMed ID: 3260790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inoculation of Macaca fascicularis with simian immunodeficiency virus, SIVmne immunologic, serologic, and pathologic changes.
    Kuller L; Morton WR; Benveniste RE; Tsai CC; Clark EA; Gale MJ; Hu SL; Thouless ME; Katze MG
    J Med Primatol; 1990; 19(3-4):367-80. PubMed ID: 2231689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [AIDS: possibilities of active immunization].
    Heinz F
    Wien Med Wochenschr; 1988 Oct; 138(19-20):535-7. PubMed ID: 3059693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.